UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

NOTICE OF EFFECTIVENESS
Effective Date: September 05, 2019
Accession Number: 0001144204-19-043011
Submission Type: POS AM
CIK: 0001541157
Company Name: Akari Therapeutics Plc
File Number: 333-227752
Akari Therapeutics (NASDAQ:AKTX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Akari Therapeutics Charts.
Akari Therapeutics (NASDAQ:AKTX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Akari Therapeutics Charts.